Abstract: A method of meliorating the inflammation and/or the progressive joint deterioration characteristic of arthritic disease, preventing the onset of asthmatic symptoms and allergic diseases, treating pain or treating bacterial and fungal infections in mammals using 3-amino-1-halogenated phenyl-2-pyrazolines and their C4 and C5 analogs.
Type:
Grant
Filed:
October 4, 1982
Date of Patent:
May 29, 1984
Assignee:
American Cyanamid Company
Inventors:
John P. Dusza, Joseph P. Joseph, Seymour Bernstein
Abstract: 3-substituted amino-1-phenyl-2-pyrazolines and 3-substituted amino-1-substituted phenyl-2-pyrazolines and their C.sub.4 and C.sub.5 analogs, useful for meliorating the inflammation and/or the progressive joint deterioration characteristic of arthritic disease, preventing the onset of asthmatic symptoms and allergic diseases, or as analgesic, antibacterial or antifungal agents.
Type:
Grant
Filed:
May 10, 1982
Date of Patent:
May 15, 1984
Assignee:
American Cyanamid Company
Inventors:
John P. Dusza, Joseph P. Joseph, Seymour Bernstein
Abstract: This disclosure describes novel 3-substituted amino-1-phenyl-2-pyrazolines and 3-substituted amino-1-mono and disubstituted phenyl-2-pyrazolines and their C.sub.4 and C.sub.5 analogs, useful for meliorating the inflammation and/or the progressive joint deterioration characteristic of arthritic disease, preventing the onset of asthmatic symptoms and allergic diseases, or as analgesic, antibacterial or antifungal agents.
Type:
Grant
Filed:
August 9, 1982
Date of Patent:
May 8, 1984
Assignee:
American Cyanamid Company
Inventors:
John P. Dusza, Joseph P. Joseph, Seymour Berstein
Abstract: Poly-cation salts of bis(or tris)[4-O-monohexose-oxy]-arylene sulfate derivatives useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and products.
Type:
Grant
Filed:
October 25, 1982
Date of Patent:
April 3, 1984
Assignee:
American Cyanamid Company
Inventors:
Janis Upeslacis, Robert E. Schaub, Seymour Bernstein
Abstract: Poly-cation salts of bis (or tris) 4-O-polyhexose-thio-arylene sulfate derivatives, useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and end products.
Type:
Grant
Filed:
October 25, 1982
Date of Patent:
March 6, 1984
Assignee:
American Cyanamid Company
Inventors:
Robert E. Schaub, Janis Upeslacis, Seymour Bernstein
Abstract: This disclosure describes certain 3-amino-1-phenyl-2-pyrazolines and 3-amino-1-substituted phenyl-2-pyrazolines and their C4 and C5 analogs useful for meliorating the inflammation and/or the progressive joint deterioration characteristic of arthritic disease, preventing the onset of asthmatic symptoms and allergic diseases, or as analgesic, antibacterial or antifungal agents.
Type:
Grant
Filed:
November 1, 1982
Date of Patent:
February 21, 1984
Assignee:
American Cyanamid Company
Inventors:
John P. Dusza, Joseph P. Joseph, Seymour Bernstein
Abstract: Poly-cation salts of bis (or tris) [4-O-polyhexose-oxy]-arylene sulfate derivatives useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and end products.
Type:
Grant
Filed:
October 25, 1982
Date of Patent:
February 14, 1984
Assignee:
American Cyanamid Company
Inventors:
Janis Upeslacis, Robert E. Schaub, Seymour Bernstein
Abstract: Poly-cation salts of bis(or tris)[4-O-monohexose-thio]-arylene sulfate derivatives useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and end products.
Type:
Grant
Filed:
October 25, 1982
Date of Patent:
February 14, 1984
Assignee:
American Cyanamid Company
Inventors:
Robert E. Schaub, Janis Upeslacis, Seymour Bernstein
Abstract: Poly-cation salts of bis (4-O-polyhexaose-thio)-phenyl urea sulfate derivatives, useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and end products.
Type:
Grant
Filed:
May 24, 1982
Date of Patent:
February 14, 1984
Assignee:
American Cyanamid Company
Inventors:
Robert E. Schaub, Janis Upeslacis, Seymour Bernstein
Abstract: Poly-cation salts of bis-(or tris-) [polyhexaose-thio (or sulfinyl, or sulfonyl)]-arylene sulfate derivatives, useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and end products.
Abstract: N,N'-Bis[4-[(2,3,4,6-tetra-O-sulfo-.alpha.(or .beta.)-D-glucopyranosyl)thio(or oxy)]phenyl]alkyl diamides, the cation salts thereof, useful as modulators of the complement system, the intermediates thereof and the process for the preparation of such intermediates and end products.
Type:
Grant
Filed:
April 16, 1982
Date of Patent:
September 13, 1983
Assignee:
American Cyanamid Company
Inventors:
Robert E. Schaub, Janis Upeslacis, Seymour Bernstein
Abstract: Bis-[.beta.-D-glucopyranosyl-1-thio (or sulfinyl or sulfonyl)]-arylene sulfate derivatives, the cation salts thereof, useful as modulators of the complement system, the intermediates thereof and the process for the preparation of such intermediates and end products.
Abstract: N,N'-Bis[4-[2,3,6-tri-O-sulfo-4-O-(2,3,4,6-tetra-O-sulfo-.alpha.(and .beta.)-D-glucopyranosyl)-.alpha.(and .beta.)-D-glucopyranosyloxy]phenyl]alkyldiamides and alkyldiamines, the cation salts thereof, useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and end products.
Type:
Grant
Filed:
April 16, 1982
Date of Patent:
August 30, 1983
Assignee:
American Cyanamid Company
Inventors:
Robert E. Schaub, Janis Upeslacis, Seymour Bernstein
Abstract: N,N'-Bis[4-[2,3,6,-tri-O-sulfo-4-O-(2,3,4,6-tetra-O-sulfo-.alpha.(and .beta.)-D-glucopyranosyl)-.alpha.(and .beta.)-D-glucopyranosylthio or sulfinyl or sulfonyl]phenyl]alkyldiamides and alkyldiamines, the cation salts thereof, useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and end products.
Type:
Grant
Filed:
April 16, 1982
Date of Patent:
August 16, 1983
Assignee:
American Cyanamid Company
Inventors:
Robert E. Schaub, Janis Upeslacis, Seymour Bernstein
Abstract: Methods of use and compositions of matter of certain ureides of substituted naphthalenesulfonic acids and salts thereof, useful as inhibitors of connective tissue destruction.
Abstract: Ureylenebis substituted (or unsubstituted) phenylenecarbonyl (or sulfonyl)-imino-1,3,5 or 6-naphthalenetrisulfonic acids and salts thereof, useful as complement inhibitors, the intermediates thereof, and the process of making such intermediates and end products.
Type:
Grant
Filed:
November 25, 1981
Date of Patent:
June 7, 1983
Assignee:
American Cyanamid Company
Inventors:
Ransom B. Conrow, John F. Poletto, Seymour Bernstein
Abstract: This disclosure describes a novel process for the production of the known antibiotic nosiheptide using a new strain of Streptomyces glaucogriseus and mutants thereof.
Type:
Grant
Filed:
September 2, 1981
Date of Patent:
May 17, 1983
Assignee:
American Cyanamid Company
Inventors:
John H. E. J. Martin, David P. Labeda, Joseph D. Korshalla, Donald B. Borders, Raymond T. Testa